Bifogade filer
Kurs
+1,66%
Likviditet
0,00 MSEK
Kalender
Est. tid* | ||
2025-11-27 | 12:00 | Kvartalsrapport 2025-Q3 |
2025-08-28 | 12:00 | Kvartalsrapport 2025-Q2 |
2025-05-28 | - | Kvartalsrapport 2025-Q1 |
2025-05-09 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2025-05-08 | - | Årsstämma |
2025-02-27 | - | Bokslutskommuniké 2024 |
2025-02-20 | - | Extra Bolagsstämma 2024 |
2024-12-05 | - | Split POLAR 300:1 |
2024-11-29 | - | Kvartalsrapport 2024-Q3 |
2024-08-30 | - | Kvartalsrapport 2024-Q2 |
2024-05-31 | - | Kvartalsrapport 2024-Q1 |
2024-05-29 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2024-05-28 | - | Årsstämma |
2024-02-23 | - | Bokslutskommuniké 2023 |
2023-11-24 | - | Kvartalsrapport 2023-Q3 |
2023-09-08 | - | Extra Bolagsstämma 2023 |
2023-08-25 | - | Kvartalsrapport 2023-Q2 |
2023-05-26 | - | Kvartalsrapport 2023-Q1 |
2023-05-17 | - | Årsstämma |
2023-05-05 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2023-03-13 | - | Extra Bolagsstämma 2022 |
2023-02-24 | - | Bokslutskommuniké 2022 |
2022-11-25 | - | Kvartalsrapport 2022-Q3 |
2022-08-26 | - | Kvartalsrapport 2022-Q2 |
2022-05-27 | - | Kvartalsrapport 2022-Q1 |
2022-05-06 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2022-05-05 | - | Årsstämma |
2022-02-25 | - | Bokslutskommuniké 2021 |
2021-11-26 | - | Kvartalsrapport 2021-Q3 |
2021-08-27 | - | Kvartalsrapport 2021-Q2 |
2021-05-28 | - | Kvartalsrapport 2021-Q1 |
2021-05-06 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2021-05-05 | - | Årsstämma |
2021-02-26 | - | Bokslutskommuniké 2020 |
2020-11-27 | - | Kvartalsrapport 2020-Q3 |
2020-08-28 | - | Kvartalsrapport 2020-Q2 |
2020-07-01 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2020-06-30 | - | Årsstämma |
2020-05-29 | - | Kvartalsrapport 2020-Q1 |
2020-02-28 | - | Bokslutskommuniké 2019 |
2020-02-14 | - | Extra Bolagsstämma 2020 |
2019-10-23 | - | Kvartalsrapport 2019-Q3 |
2019-07-24 | - | Kvartalsrapport 2019-Q2 |
2019-05-07 | - | Split POLAR 16:1 |
2019-04-26 | - | Kvartalsrapport 2019-Q1 |
2019-03-19 | - | Årsstämma |
2019-02-04 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
2019-02-01 | - | Bokslutskommuniké 2018 |
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Medicinteknik |
PolarCool AB (publ.), the Swedish med-tech company behind the concussion treatment product PolarCap®, has renewed its agreement with English Premiership Rugby team Bristol Bears. The extension, which runs for another two years, reinforces PolarCool's growing footprint in professional rugby.
PolarCool develops and markets the product PolarCap®, which alleviates the effects of concussion. The UK and European rugby markets remain a central focus for PolarCool's expansion strategy. The extended partnership with Bristol Bears-a premier club competing in England's top-tier Gallagher Premiership - marks a significant step in the company's growth. As one of the leading rugby organizations in the UK, Bristol Bears plays a key role in strengthening PolarCool's presence in elite-level sport across the region.
PolarCool CEO Erik Andersson comments
-Bristol Bears have built a reputation for high performance standards and strong player care. The fact that the club continues to use PolarCap® is, in my view, a testament to their appreciation of the product's value as an acute treatment for sports-related concussions and their commitment to player wellbeing.
The United Kingdom remains a key market for PolarCool, with a numerous professional teams in both professional rugby and football. Following the recent signing of Southampton FC, a leading English football club, alongside the renewed agreement with Bristol Bears, PolarCool continues to expand its footprint across both sports.
PolarCool's goal is to continue to strengthen its presence in international rugby and the agreement therefore brings strategic value.
For more information
Erik Andersson - CEO PolarCool AB (publ.)
+46 - 738 60 57 00
E-mail: erik.andersson@polarcool.se